Pedro Mendes-Ferreira

Therapeutic potential of neuregulin-1 in cardiovascular disease.

Myocardial and anti-inflammatory effects of chronic bosentan therapy in monocrotaline-induced pulmonary hypertension.

Angiotensin-(1-7) modulates angiotensin II-induced vasoconstriction in human mammary artery.

Neuregulin-1 improves right ventricular function and attenuates experimental pulmonary arterial hypertension.

Pulmonary arterial hypertension: Basic knowledge for clinicians.

Improvement in left intraventricular pressure gradients after aortic valve replacement in aortic stenosis patients.

Loss of KCNK3 is a hallmark of RV hypertrophy/dysfunction associated with pulmonary hypertension.

Urocortin-2 improves right ventricular function and attenuates pulmonary arterial hypertension.

Neuregulin-1 attenuates right ventricular diastolic stiffness in experimental pulmonary hypertension.

Bmpr2 Mutant Rats Develop Pulmonary and Cardiac Characteristics of Pulmonary Arterial Hypertension.

The effect of different anaesthetics on echocardiographic evaluation of diastolic dysfunction in a heart failure with preserved ejection fraction model.

Efficacy of the thromboxane receptor antagonist NTP42 alone, or in combination with sildenafil, in the sugen/hypoxia-induced model of pulmonary arterial hypertension.

Kcnk3 dysfunction exaggerates the development of pulmonary hypertension induced by left ventricular pressure overload.

Iron Deficiency in Pulmonary Arterial Hypertension: A Deep Dive into the Mechanisms.

The adult heart requires baseline expression of the transcription factor Hand2 to withstand right ventricular pressure overload.

Cardiac and Pulmonary Vascular Dysfunction in Vitamin D-Deficient -Mutant Rats.

The thromboxane receptor antagonist promotes beneficial adaptation and preserves cardiac function in experimental models of right heart overload.

Human-umbilical cord matrix mesenchymal cells improved left ventricular contractility independently of infarct size in swine myocardial infarction with reperfusion.